Amino9® (Clinically Validated EAA Blend)

Evidence Level
Strong
1 Clinical Trial
3 Documented Benefits
4/5 Evidence Score

Amino9® (Compound Solutions) is a patented blend of all nine essential amino acids (EAAs) in a clinically validated ratio specifically optimized for muscle protein synthesis. Unlike BCAAs (which provide only leucine, isoleucine, and valine) or incomplete amino acid blends, Amino9® provides all nine indispensable amino acids required for complete muscle protein synthesis — with clinical data showing superior MPS stimulation compared to leucine alone and BCAA-only formulas. Amino9® is backed by a published RCT demonstrating significant muscle protein synthesis enhancement vs. control.

Studied Dose 5.6g Amino9® per serving (clinical dose used in published RCT); typically 5–10g/day; pre, intra, or post-workout
Active Compound All 9 essential amino acids in clinically optimized ratio — L-leucine, L-isoleucine, L-valine, L-lysine, L-threonine, L-methionine, L-phenylalanine, L-histidine, L-tryptophan; Amino9® by Compound Solutions

Complete muscle protein synthesis stimulation

Amino9® provides all nine EAAs in the ratios required for complete muscle protein synthesis — addressing the fundamental limitation of BCAA-only supplements that lack the full complement of amino acids needed to build new muscle proteins. A published RCT confirmed Amino9® significantly increases muscle protein synthesis rates vs. control, with superior outcomes to leucine-only and incomplete EAA approaches.

Greater MPS than BCAAs or leucine alone

Muscle protein synthesis requires all EAAs as substrates. BCAA supplementation (leucine, isoleucine, valine only) stimulates mTORC1 signaling but lacks the amino acid building blocks for complete protein synthesis — resulting in partial stimulation that 'borrows' other EAAs from existing muscle proteins. Amino9®'s complete EAA profile eliminates this bottleneck for superior net protein accretion.

Lean muscle preservation during caloric deficit

During caloric restriction or intermittent fasting, EAA supplementation with Amino9® provides the complete amino acid stimulus for muscle protein synthesis without caloric load, helping preserve lean muscle mass. This anti-catabolic application is particularly valuable for weight loss, athletic cutting phases, and aging populations combating sarcopenia.

1

Complete EAA delivery for maximal MPS

Muscle protein synthesis is rate-limited by the least abundant essential amino acid available (Liebig's Law of the Minimum applied to protein synthesis). Amino9® provides all nine EAAs in optimized ratios, ensuring no single EAA becomes limiting. Leucine triggers mTORC1/p70S6K signaling to initiate MPS, while the remaining eight EAAs serve as substrates for peptide bond formation — enabling full protein synthesis rather than just signaling initiation.

1
Amino9® Essential Amino Acids and Muscle Protein Synthesis — RCT
PubMed

Randomized, controlled trial examining Amino9® (5.6g EAA blend) effects on muscle protein synthesis rates vs. control in resistance-trained individuals.

Resistance-trained adults. Clinical MPS measurement study.

Amino9® significantly increased fractional synthetic rate of muscle protein synthesis vs. control. Superior MPS stimulation compared to leucine alone and BCAA-only comparisons. Supports Amino9® as a complete EAA supplement for muscle building and anti-catabolic applications.

Common Potential side effects

Excellent safety profile — essential amino acids are normal dietary components
Mild GI effects at very high doses (>20g) — stay within clinical range
Phenylketonuria (PKU) — contains phenylalanine; contraindicated in PKU

Important Drug interactions

mTOR inhibitors — EAAs activate mTOR; theoretical reduced drug efficacy in transplant immunosuppression
No significant drug interactions at clinical doses